Alcon AG Valuation
| ALC Stock | CHF 60.12 0.90 1.47% |
At this time, the firm appears to be overvalued. Alcon AG shows a prevailing Real Value of ₣48.7 per share. The current price of the firm is ₣60.12. Our model approximates the value of Alcon AG from analyzing the firm fundamentals such as profit margin of 0.10 %, and Return On Equity of 0.0482 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Alcon AG's price fluctuation is very steady at this time. Calculation of the real value of Alcon AG is based on 3 months time horizon. Increasing Alcon AG's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Alcon stock is determined by what a typical buyer is willing to pay for full or partial control of Alcon AG. Since Alcon AG is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alcon Stock. However, Alcon AG's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 60.12 | Real 48.7 | Hype 60.12 |
The intrinsic value of Alcon AG's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alcon AG's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alcon AG helps investors to forecast how Alcon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alcon AG more accurately as focusing exclusively on Alcon AG's fundamentals will not take into account other important factors: About Alcon AG Valuation
Our relative valuation model uses a comparative analysis of Alcon AG. We calculate exposure to Alcon AG's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alcon AG's related companies.Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. operates independently of Novartis AG as of April 9, 2019. ALCON N operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 20000 people.
Additional Tools for Alcon Stock Analysis
When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.